Enesi Pharma Presenting at the BIO CEO & Investor Conference, New York

OXFORD, UK – 31 January 2020 – Enesi Pharma (“Enesi”), the innovative pharmaceutical company developing unique needle-free, unit solid dose vaccines, is attending and presenting at the upcoming BIO CEO & Investor Conference in New York, USA taking place from 10th – 11th February 2020.

David Hipkiss, CEO, will be presenting Enesi’s innovative ImplaVax® platform on Monday 10th February 2020 at 1.45pm in the Wilder Room at the Marriott Marquis Hotel, 1535 Broadway, New York.